🇺🇸 FDA
Patent

US 10329298

Inhibitors of cellular metabolic processes

granted A61PA61P35/00A61P35/02

Quick answer

US patent 10329298 (Inhibitors of cellular metabolic processes) held by Agios Pharmaceuticals, Inc. expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00